1-4 of 4
Claudio A. Mosse
Close
Sort by
Journal Articles

Recommendation on Advanced Molecular Testing in Hematolymphoid Malignancies in the Veterans Population

Jadee L Neff, Claudio A. Mosse, Jessica Wang-Rodriguez, Sara Ahmed, Michael Kelley
Journal: Blood
Blood (2021) 138 (Supplement 1): 4983.
https://doi.org/10.1182/blood-2021-154362
Published: 2021
Journal Articles

In the Era of Bortezomib-Based Chemotherapy the Presence of Minimal Residual Disease Predicts Progression Free Survival after Autologous Hematopoietic Cell Transplant

Robert F Cornell, MD MS, Jade E Jones, Claudio A. Mosse, Heidi Chen, Laura Dugger, Salil Goorha, Wichai Chinratanalab, Brian Engelhardt, Stacey A. Goodman, MD MS, John P Greer, Shelton Lacy, Adetola A. Kassim, MD MS, Kevin McDonagh, Bipin N. Savani, MD, Salyka Sengsayadeth, Madan Jagasia
Journal: Blood
Blood (2015) 126 (23): 5493.
https://doi.org/10.1182/blood.V126.23.5493.5493
Published: 2015
Journal Articles

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Adam C. Seegmiller, MD, PhD, Annette S. Kim, MD, PhD, Claudio A. Mosse, MD, PhD, Mia A. Levy, MD, PhD, Mary Ann Thompson, MD, PhD, Megan K. Kressin, MD, Madan H. Jagasia, MD, Stephen A. Strickland, MD, MSCI, Nishitha M. Reddy, MD, Kristy J. Sinkfield, Samuel A. Santoro, MD, PhD, Mary M. Zutter, MD
Journal: Blood
Blood (2011) 118 (21): 2073.
https://doi.org/10.1182/blood.V118.21.2073.2073
Published: 2011
Journal Articles

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF

Yuhui Huang, Xiaolan Chen, Mikhail M. Dikov, Sergey V. Novitskiy, Claudio A. Mosse, Li Yang, David P. Carbone
Journal: Blood
Blood (2007) 110 (2): 624–631.
https://doi.org/10.1182/blood-2007-01-065714
Published: 2007